DOCSLIB.ORG

A4-ENG-INS-IDT9000S-General Screening Drugs-V2-30 Drug List.Cdr

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A4-ENG-INS-IDT9000S-General Screening Drugs-V2-30 Drug List.Cdr Procedure Card for IDT9000S GENERAL ® TM SCREENING DRUGS INSTRUCTIONS TESTING KITS FOR DRUGS SNIFFER Test Kit As a precaution, gloves and eye protection should be worn when handling drug Read substances and using test units. Do not puncture any part of unit. Do not remove probe Before once a capsule is broken. In the unlikely event of a spill, rinse affected area thoroughly with water. Keep out of reach of children. All results are presumptive. If necessary, further Complete Steps 1-7 before proceeding. Use testing by a competent drug testing lab can provide additional identification. Gently insert Remove the Smart- Remove the The kit is not for Cocaine or Marijuana testing. Use Cocaine/Crack Sniffer Test Kit Tip™ probe from cover paper the Accessory the appropriate from the Smart- (IDT1000S) or Marijuana/Hashish Sniffer Test Kit (IDT3300S) to test for those drugs. 1 into the Sniffer. 2 3 tion test kit. Tip™ probe. a Push until a click With thumb and forefinger, Gently shake test unit sound is heard. squeeze chamber 1 until epar for 2-3 seconds. r 8 9 CLICK! Do not capsule breaks. touch the tion est P T adhesive. Accessory Sniffer Chamber 1 Identifica Insert the Smart-Tip™ Collect particles from the probe into the Accessory with the adhesive area suspect surface. Vacuum 4 5 up to 10 seconds. tion facing out from the Sniffer. Important: a If a brown powder is present, the appearance of a purple-red color Adhesive Push down the Suspect Smart-TipTM strongly indicates the presence of Brown Heroin. epar located on the Surface r If a brown powder is not present, the appearance of a purple-red FRONT of probe until it is completely color indicates the presence of a drug listed in Chamber 2 Results. est P the probe for T collecting locked into the Do not use If a purple-red color develops, proceed to Disposal. sampling unit. Results If no purple-red color develops, proceed to Step 10. particles MAX power. Chamber 1 * Note: The liquid remaining the yellow color of the reagent or a blue-green color on the adhesive, does not indicate a positive result. STOP Remove the Smart-Tip™ Lock Smart-Tip™ probe into test unit. Do not probe from the Sniffer. With thumb and forefinger, Gently shake test unit 6 7 Press firmly. continue squeeze chamber 2 until tion unless a for 2-3 seconds. probe is 10 capsule breaks. 11 locked tion epar r below the Flex Flex Pins and cannot est P T Pins be removed Chamber 2 from the Identifica test unit. CONTINUE TO KIT INSTRUCTIONS ON OTHER SIDE. The appearance of a purple-red color indicates the presence of one of the following drugs: • Use only Sniff & KnowTM Detection Kits with the Sniffer. Heroin, Amphetamine, Methamphetamine, Ecstasy/MDMA, Buphedrone, Cathinone, DMT, Ketamine, Mephedrone, • The Sniffer can be used for screening suspected people, clothing, hands, Methadone, MethCathinone, Methylone, mCPP, MDMAI, • packages, shipping containers, and vehicles. MDPBP, MDPV, MPA, PCP, Pentylone, PMA, PMMA, • The Sniffer is for relatively clean surfaces. 2-aminoindane, 3-Methylbutyrfentanyl, 3-Methylfentanyl, 4-Fluorobutyrfentanyl, 4-Fluoroisobutyrfentanyl, • Make sure to use the proper instructions. Testing procedures may vary for Results Chamber 2 4-Methoxybutyrfentanyl, other synthetic/designer drugs. ting Notes a • different types of detection kits. Using the wrong instructions may lead to If no purple-red color develops, • improper identification. the above listed drugs are not present. Oper • For optimum Sniffer operation time, do not use maximum (MAX) power. * Note: The liquid remaining the yellow color of the reagent or a blue-green color on the adhesive, does not indicate a positive result. • For maintenance and troubleshooting see the Sniffer Operating Manual. v2 Disposal The test kit is safe to dispose of in the trash. 30list 01-19 Manufactured by IDenta Ltd Manufactured by IDenta Ltd IDenta www.identa-corp.com IDenta www.identa-corp.com World Leader in Patented Technology • Made in Israel World Leader in Patented Technology • Made in Israel Forensic Products Forensic Products.
Load more

Recommended publications
  • General Drug and Explosive Detection
    Ζ'HQWDȇV'UXJ'HWHFWLRQDQGΖGHQWLILFDWLRQWHVWNLWVRIIHUEUHDNWKURXJKLQQRYDWLRQVORQJ DZDLWHGE\WKHIRUHQVLFPDUNHW8QWLOUHFHQWO\RQO\GLIILFXOWWRXVHDQGKDUGWRXQGHUVWDQG WHVWNLWVZLWKPDQ\FRQVWUDLQWVDQGOLPLWDWLRQVZHUHDYDLODEOHΖ'HQWDȇVNLWVPDNHWKH WDVNVIDFHGE\SDUHQWVHGXFDWRUVHPSOR\HUVDQGODZHQIRUFHPHQWRIILFHUVHDVLHU IDVWHUIDUVDIHUDQGPRUHFRVWHIIHFWLYHWKDQDQ\VLPLODUNLWDYDLODEOH .H\%HQHILWV .H\0DUNHWV ႑(DV\IDVWDQGVLPSOHWRXVH1RRWKHUWHVWVDUH ႑/DZHQIRUFHPHQW DVVWUDLJKWIRUZDUG ႑0LOLWDU\ ႑$FFXUDWHDQGUHOLDEOHDWH[WUHPHWHPSHUDWXUHV ႑&XVWRPV ႑&OHDUUHVXOWVLQVHFRQGV ႑6HFXULW\DJHQFLHV ႑/RQJVKHOIOLIH XSWR\HDUV ZLWKQRVWRUDJH ႑*RYHUQPHQWDJHQFLHV UHVWULFWLRQV ,'7 '($)%Ζ&Ζ$ ,'7 ,'7 ႑6DIH$FWXDOO\YHU\VDIH1RFRQWDFWZLWK *HQHUDO6FUHHQLQJ ႑3ULVRQV FKHPLFDOVRUVXEVWDQFHV1RLQKDODWLRQRI .HWDPLQH /LTXLG *+% 'UXJV &RUSRUDWH+5GHSDUWPHQWV YDSRUVQRSURWHFWLYHJHDUQHHGHG ႑ ΖGHQWLILFDWLRQ ΖGHQWLILFDWLRQ ΖGHQWLILFDWLRQ ႑6DIHWRGLVSRVH6HOIFRQWDLQHGQHXWUDOL]DWLRQ ႑3ULYDWHUHVLGHQFHV )LHOG7HVW.LW ႑6PDOODQGYHU\UXJJHG ႑6FKRROV8QLYHUVLWLHV )LHOG7HVW.LW )LHOG7HVW.LW ႑&DQEHXVHGDQ\ZKHUHDQ\WLPH ႑5HKDELOLWDWLRQIDFLOLWLHV ႑7KHFRORUWHVWLVEDVHGRQWKHVDPHFKHPLVWU\DV ႑ƀ+\GUR[\EXW\ULFDFLG *+% LVDFHQWUDO ႑7KHWHVWGHWHFWVGUXJVLQFOXGLQJFRFDLQH ႑$YDLODEOHZLWKYDULRXVSUREHV ႑%RUGHUFRQWURO IRUWKHVROLGWHVW QHUYRXVV\VWHPGHSUHVVDQWXVHGDVDQ KHURLQDPSKHWDPLQHHFVWDV\DVZHOODVQHZ 7RXFK6ZLSH6QLIIHURU6DPSOHU LQWR[LFDQW GHVLJQHUGUXJV ႑(PHUJHQF\URRPV ႑7KHNLWFRQWDLQVDQRYHOVDPSOHUIRUWKHHDV\ ႑2XUNLWV'2WHVWOLTXLGV WHVWLQJRIOLTXLGV ႑&RPPRQVWUHHWQDPHVLQFOXGH*/LTXLG ႑7KHWHVWLVEDVHGRQDQRYHOFRORUWHVWIRU */LTXLG;/LTXLG(*HRUJLD+RPH%R\ DONDORLGV
    [Show full text]
  • Aminoindanesthe Next Wave of Legal Highs?
    Drug Testing Review and Analysis Received: 23 May 2011 Accepted: 24 May 2011 Published online in Wiley Online Library: 11 July 2011 (www.drugtestinganalysis.com) DOI 10.1002/dta.318 Aminoindanes – the next wave of ‘legal highs’? P.D. Sainsbury,a A.T. Kicman,a R.P. Archer,b L.A. Kinga and R.A. Braithwaitea∗ Due to its closed ring system, 2-aminoindane is a conformationally rigid analogue of amphetamine. Internet websites offering synthetic compounds as ‘research chemicals’ have recently been advertising 5,6-methylenedioxy-2-aminoindane (MDAI), 5, 6-methylenedioxy-N-methyl-2-aminoindane (MDMAI), 5-iodo-2-aminoindane (5-IAI), and 5-methoxy-6-methyl-2-aminoindane (MMAI). The chemistry, pharmacology, and toxicological aspects of this new class of psychoactive substances are reviewed, as these could become the next wave of ‘legal highs’. Copyright c 2011 John Wiley & Sons, Ltd. Keywords: aminoindanes; legal highs; MDAI; MDMAI; 5-IAI; MMAI; serotonin. Introduction Pharmacology Although Solomons and Sam reported in 1973 that the aminoin- Historically, the terms ‘legal highs’ and ‘herbal highs’ referred to danes possessed significant bronchodilating and analgesic blends of psychoactive plants or fungi that could be smoked properties,[2] more recent research points to the aminoindanes as or ingested to induce dissociative effects and hallucinations. having potent effects on serotonin release and re-uptake. A num- These terms, however, have more recently been widened to ber of studies undertaken in the late 1980s and early 1990s con- describe an extensive and growing range of entirely synthetic cerning Ecstasy (3,4-methylenedioxymethamphetamine; MDMA) substances that have become popular as recreational drugs of also included a comparison with a number of MDMA analogues abuse; this coincides with a period of intense media interest that incorporated an indane ring.
    [Show full text]
  • CREW NPS Booklet
    NEW Psychoactive DRUGS V1.7 05/15 Service availability Drop-in: Monday – Wednesday: 1pm – 5pm, Thursday: 3pm – 7pm, Friday – Saturday: 1pm – 5pm, Sunday: Closed Telephone information and support: Monday – Friday: 10am – 5pm Online information and chatroom support: www.mycrew.org.uk Address | 32 Cockburn Street | Edinburgh | EH1 1PB Telephone | 0131 220 3404 Email | [email protected] Main | www.crew2000.org.uk Enterprise | www.mindaltering.co.uk Info and support | www.mycrew.org.uk Facebook | www.facebook.com/Crew2000 Twitter | www.twitter.com/Crew_2000 Instagram | www.instagram.com/Crew_2000 This booklet has been designed to expand worker knowledge and confidence in the area of NPS. It is most useful when discussed as part of Crew’s NPS training. Crew was established in 1992, in response to the rapid expansion of recreational drug use. We provide up-to-date information on the drugs that people are taking so they can make informed decisions about their own health. This is achieved using a stepped care approach and through collaboration with volunteers, service users and professionals. Crew neither condemns nor condones drug use, but we believe there are ways to reduce harm to health. As a national agency, Crew is at the forefront of emerging drug trends and we engage at all levels including service development, practice and policy. Our services include: – Support line: non-judgmental drug and sexual health information and support. – Drop-in: drug and sexual health information, condoms (NHS c:card service) and DJ workshops. – Outreach services: we provide welfare at large events, such as clubs and festivals to educate revellers on partying safely.
    [Show full text]
  • Download Author Version (PDF)
    Analyst An Overview of Recent Developments in the Analytical Detection of New Psychoactive Substances (NPSs) Journal: Analyst Manuscript ID: AN-MRV-04-2015-000797.R1 Article Type: Minireview Date Submitted by the Author: 18-May-2015 Complete List of Authors: Banks, Craig; Manchester Metropolitan University, Chemistry Smith, Jamie; Manchester Metropolitan University, Chemistry Manchester, United Kingdom, Sutcliffe, Oliver; Manchester Metropolitan University, Page 1 of 41 Analyst 1 2 3 An Overview of Recent Developments in the Analytical Detection 4 5 6 of New Psychoactive Substances (NPSs) 7 8 9 10 11 12 13 14 Jamie P. Smith, Oliver B. Sutcliffe and Craig E. Banks* 15 16 17 18 19 20 Faculty of Science and Engineering, School of Chemistry and the Environment, 21 22 Division of Chemistry and Environmental Science, Manchester Metropolitan University, 23 Chester Street, Manchester M1 5GD, Lancs, UK 24 25 26 27 28 29 30 31 32 33 34 35 36 Submission to: Analyst 37 38 39 40 41 42 43 44 45 46 47 48 49 *To whom correspondence should be addressed. 50 51 Email: [email protected]; Tel: +44(0)1612471196; Fax: +44(0)1612476831 52 53 54 55 56 57 58 59 60 1 Analyst Page 2 of 41 1 2 3 Abstract 4 5 6 Novel psychoactive substances (NPSs), sometimes referred to as “legal highs” in 7 8 more colloquial environments/the media, are a class of compounds that have been recently 9 10 made available for abuse (not necessarily recently discovered) which provide similar effects 11 to the traditional well studied illegal drugs but are not always controlled under existing local, 12 13 regional or international drug legislation.
    [Show full text]
  • New Psychoactive Substances (NPS)
    New Psychoactive Substances (NPS) LGC Quality Reference ISO 9001 ISO/IEC 17025 ISO Guide 34 materials GMP/GLP ISO 13485 2019 ISO/IEC 17043 Science for a safer world LGC offers the most extensive and up-to-date range of New LGC is a global leader in Psychoactive Substances (NPS) measurement standards, reference materials. reference materials, laboratory services and proficiency testing. With 2,600 professionals working When you make a decision using The challenge The LGC response We are the UK’s in 21 countries, our analytical our resources, you can be sure it’s designated National measurement and quality control based on precise, robust data. And New Psychoactive Substances In response to the ever-expanding LGC Standards provides the widest Measurement services are second-to-none. together, we’re creating fairer, safer, (NPS) continue to be identified, range of NPS being developed, LGC range of reference materials Institute for chemical more confident societies worldwide. and it appears that moves by the has produced a comprehensive available from any single supplier. and bioanalytical As a global leader, we provide the United Nations and by individual range of reference materials that We work closely with leading widest range of reference materials lgcstandards.com countries to control lists of meet the rapidly changing demands manufacturers to provide improved measurement. available from any single supplier. named NPS may be encouraging of the NPS landscape. Many of access to reference materials, the development of yet further these products are produced under with an increasingly large range variants to avoid these controls. the rigorous quality assurance of parameters, for laboratories standards set out in ISO Guide 34.
    [Show full text]
  • Controlled Substances List (Adopted by Alabama State Board of Health on January 20, 2021, Effective January 20, 2021)
    1 Controlled Substances List (Adopted by Alabama State Board of Health on January 20, 2021, effective January 20, 2021) Schedule I (a) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it. (b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation (for purposes of 3-methylthiofentanyl only, the term isomer includes the optical and geometric isomers): (1) Acetyl-alpha-methylfentanyl (N-[1-[1-methyl-2-phenethyl]-4-piperidinyl]- N-phenylacetamide -------------------------------------------------------------------- 9815 (Federal Control Nov. 29, 1985; State Dec. 29, 1985) (2) Acetylmethadol ------------------------------------------------------------------------- 9601 (3) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl] benzamide -------------------------------------------------------------------------------- 9551 Federal Control May 16, 2016; State June 15, 2016 (4) Allylprodine ----------------------------------------------------------------------------- 9602 (5) Alphacetylmethadol --------------------------------------------------------------------- 9603 (6) Alphameprodine
    [Show full text]
  • Chapter 420-7-2 Controlled Substances
    Health Chapter 420-7-2 ALABAMA STATE BOARD OF HEALTH ALABAMA DEPARTMENT OF PUBLIC HEALTH ADMINISTRATIVE CODE CHAPTER 420-7-2 CONTROLLED SUBSTANCES TABLE OF CONTENTS 420-7-2-.01 Authority 420-7-2-.02 Definitions 420-7-2-.11 Prescription Drug Monitoring Program – Collection Of Fees To Support Database 420-7-2-.12 Prescription Drug Monitoring Program Reporting To Database By Dispensers 420-7-2-.13 Access To Database Appendix Controlled Substances List 420-7-2-.01 Authority. (1) The Alabama Controlled Substances List, shown as Appendix to this Chapter, comprises a complete listing of said substances, pursuant to Code of Ala. 1975, Sections 20-2-1, et seq. (2) The Controlled Substances List shall be published annually, reflecting the date of adoption and the effective date. (3) As substances are designated, rescheduled or deleted as controlled substances, the appendix and other publications shall be amended accordingly by adding to said listing a slip-sheet of the action taken and the effective date. Each annual publication, as provided in (2) above, will contain any amendment occurring during that year. Author: Alabama Department of Public Health Statutory Authority: Code of Ala. 1975, §§20-2-1, et seq. History: Filed September 1, 1982. 420-7-2-.02 Definitions. Supp. 12/31/16 7-2-1 Chapter 420-7-2 Health (1) Controlled Substance. A drug, substance or immediate precursor in Schedules I through V of Rule 420-7-2-.03 of this Chapter. (2) Drug. (a) Substances recognized as drugs in the official United States pharmacopoeia, official homeopathic pharmacopoeia of the United States or official national formulary or any supplement to any of them; (b) Substances intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in man or animals; (c) Substances (other than food) intended to affect the structure or any function of the body of man or animals; and (d) Substances intended for use as a component of any article specified in paragraphs (a), (b) or (c) of this subdivision.
    [Show full text]
  • “The Short History of New Psychoactive Substances in Ukraine”
    “THE SHORT HISTORY OF NEW PSYCHOACTIVE SUBSTANCES IN UKRAINE” UNITED NATIONS OFFICE ON DRUGS AND CRIME Vienna “The short history of New Psychoactive substances in Ukraine” Historic overview of the origins, distribution, and patterns of use of New Psychoactive substances/Stimulants and current challenges and solutions for harm reduction programmes Ukraine, 2020 4 This translation was made by UNODC Regional Programme Office for Eastern Europe (UNODC RPOEE). UNODC RPOEE is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition. The short history of New Psychoactive substances in Ukraine. © Regional Program Office for Eastern Europe of the United Nations Office on Drugs and Crime, 2020 Rights protected. The document may be copied, distributed and adapted for non-commercial purposes provided that reference is made to this document, as set out below. In any case, the use of this document does not imply that UNODC approves any particular organization, product or service. Unauthorized use of the names or logos of the UNODC is not allowed. Adaptation of this document requires permission from UNODC RPOEE. In the case of a translation of the document text, an explanatory note is provided together with the proposed quotation: "This translation was not created by the United Nations Office on Drugs and Crime (UNODC). UNODC is not responsible for the content or accuracy of this translation. The original version in English is a legally binding authentic edition". Any mediation in disputes is carried out in accordance with the rules of the UNDOC. Recommended citation. The short history of New Psychoactive substances in Ukraine, Kyiv, 2020 Third party materials.The use of third-party materials in this document, such as tables, figures or photographs, places the user's responsibility for obtaining permission for such use from third parties and permission from the copyright owner.
    [Show full text]
  • 1 SB333 2 158141-2 3 by Senator Orr 4 RFD: Judiciary 5 First Read: 11-FEB-14
    1 SB333 2 158141-2 3 By Senator Orr 4 RFD: Judiciary 5 First Read: 11-FEB-14 Page 0 SB333 1 SB333 2 3 4 ENROLLED, An Act, 5 Relating to Schedule I controlled substances; to 6 amend Sections 13A-12-231 and 20-2-23, Code of Alabama 1975, 7 to increase the requisite weight for trafficking in controlled 8 substance analogues; to include additional synthetic 9 controlled substances and analogues to the Schedule I 10 controlled substances list; and in connection therewith would 11 have as its purpose or effect the requirement of a new or 12 increased expenditure of local funds within the meaning of 13 Amendment 621 of the Constitution of Alabama of 1901, now 14 appearing as Section 111.05 of the Official Recompilation of 15 the Constitution of Alabama of 1901, as amended. 16 BE IT ENACTED BY THE LEGISLATURE OF ALABAMA: 17 Section 1. This act shall be known and may be cited 18 as Landon's Law. 19 Section 2. Sections 13A-12-231 and 20-2-23, Code of 20 Alabama 1975, are amended to read as follows: 21 "§13A-12-231. 22 "Except as authorized in Chapter 2, Title 20: 23 "(1) Any person who knowingly sells, manufactures, 24 delivers, or brings into this state, or who is knowingly in 25 actual or constructive possession of, in excess of one kilo or Page 1 SB333 1 2.2 pounds of any part of the plant of the genus Cannabis, 2 whether growing or not, the seeds thereof, the resin extracted 3 from any part of the plant, and every compound, manufacture, 4 salt, derivative, mixture, or preparation of the plant, its 5 seeds, or resin including the completely defoliated
    [Show full text]
  • Armenia Criminal Code As of 23 May 2018
    Strasbourg, 12 March 2021 CDL-REF(2021)022 Opinion No. 1026 / 2021 Engl. only EUROPEAN COMMISSION FOR DEMOCRACY THROUGH LAW (VENICE COMMISSION) ARMENIA CRIMINAL CODE AS OF 23 MAY 2018 (*) (*) Translation provided by the Armenian authorities This document will not be distributed at the meeting. Please bring this copy. www.venice.coe.int CDL-REF(2021)022 - 2 - CRIMINAL CODE OF THE REPUBLIC OF ARMENIA (Adopted on 18 April 2003) GENERAL PART SECTION 1 CRIMINAL STATUTE CHAPTER 1 TASKS AND PRINCIPLES OF CRIMINAL LEGISLATION Article 1. Criminal legislation of the Republic of Armenia 1. The criminal legislation of the Republic of Armenia consists of this Code. New laws that envisage criminal liability shall be included in the Criminal Code of the Republic of Armenia. 2. The Criminal Code of the Republic of Armenia is based on the Constitution of the Republic of Armenia and on principles and norms of international law. Article 2. Tasks of the Criminal Code of the Republic of Armenia 1. Tasks of the Criminal Code of the Republic of Armenia shall be as follows: to protect human and citizens’ rights and freedoms from criminal encroachments, rights of legal entities, property, environment, public order and security, constitutional order, peace and safety of humanity, as well as to prevent crimes. 2. For the purpose of implementing these tasks, the Criminal Code of the Republic of Armenia stipulates the ground for criminal liability and the principles of criminal legislation, determines what acts dangerous to the public are deemed to be crimes and defines the types of punishment and other criminal-law enforcement measures for commission thereof.
    [Show full text]
  • New Psychoactive Drugs – Crew2000
    NEW Psychoactive DRUGS V1.8 01/16 Service availability Drop-in: Monday – Wednesday: 1pm – 5pm, Thursday: 3pm – 7pm, Friday – Saturday: 1pm – 5pm, Sunday: Closed Telephone information and support: Monday – Friday: 10am – 5pm Online information and chatroom support: www.mycrew.org.uk Address | 32 Cockburn Street | Edinburgh | EH1 1PB Telephone | 0131 220 3404 Email | [email protected] Main | www.crew2000.org.uk Enterprise | www.mindaltering.co.uk Info and support | www.mycrew.org.uk Facebook | www.facebook.com/Crew2000 Twitter | www.twitter.com/Crew_2000 Instagram | www.instagram.com/Crew_2000 This booklet has been designed to expand worker knowledge and confidence in the area of NPS. It is most useful when discussed as part of Crew’s NPS training. Crew was established in 1992, in response to the rapid expansion of recreational drug use. We provide up-to-date information on the drugs that people are taking so they can make informed decisions about their own health. This is achieved using a stepped care approach and through collaboration with volunteers, service users and professionals. Crew neither condemns nor condones drug use, but we believe there are ways to reduce harm to health. As a national agency, Crew is at the forefront of emerging drug trends and we engage at all levels including service development, practice and policy. Our services include: – Support line: non-judgmental drug and sexual health information and support. – Drop-in: drug and sexual health information, condoms (NHS c:card service) and DJ workshops. – Outreach services: we provide welfare at large events, such as clubs and festivals to educate revellers on partying safely.
    [Show full text]
  • Designer Drug (DD) Abuse in Poland; a Review of the Psychoactive And
    Annals of Agricultural and Environmental Medicine 2012, Vol 19, No 4, 857-870 MISCELLANEOUS www.aaem.pl Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part 1 – Cannabinoids and Cathinones Przemysław Biliński1,2, Piotr Hołownia1, Lucyna Kapka-Skrzypczak3,4, Andrzej Wojtyła5,6 1 Chief Sanitary Inspectorate, Warsaw, Poland 2 Institute of Haematology and Transfusion Medicine, Warsaw, Poland 3 Independent Laboratory of Molecular Biology, Institute of Rural Health, Lublin, Poland 4 Department of Public Health, University of Information Technology and Management, Rzeszow, Poland 5 Department of Mother and Child Health, University of Medical Sciences, Poznan, Poland 6 Department of Hygiene, Chair of Social Medicine, University of Medical Sciences, Poznan, Poland Biliński P, Hołownia P, Kapka-Skrzypczak L, Wojtyła A. Designer Drug (DD) abuse in Poland. A review of the psychoactive and toxic properties of substances found during seizures of illegal drug products and resulting legal consequences. Part I – Cannabinoids and Cathinones. Ann Agric Environ Med. 2012; 19(4): 857-870. Abstract Faced with the rapidly growing increase of designer drug abuse, particularly amongst the younger generation, various legislative strategies are currently employed world-wide for tackling this problem – however with mixed results. The key issue is that the producers of DDs are able to either exploit existing legal substances intended for other uses, but which have been found to possess psychoactive properties, or to synthesise new psychoactive substances by introducing chemical modications, often very minor ones, thereby avoiding the prohibited use of chemicals included on any banned lists.
    [Show full text]